NCT06384573View on ClinicalTrials.gov

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Alzheimer's DiseaseDementiaAlzheimer's Disease, Familial
Interventions
DRUG

lecanemab

Administered intravenously

Trial Locations (6)

2031

RECRUITING

Neuroscience Research Australia, Randwick

35294

ACTIVE_NOT_RECRUITING

University of Alabama in Birmingham, Birmingham

46202

ACTIVE_NOT_RECRUITING

Indiana University School of Medicine, Indianapolis

63110

ACTIVE_NOT_RECRUITING

Washington University in St. Louis, St Louis

98195

ACTIVE_NOT_RECRUITING

University of Washington, Seattle

WC1B 3BG

RECRUITING

The National Hospital for Neurology and Neurosurgery, London

All Listed Sponsors
collaborator

Alzheimer's Association

OTHER

collaborator

Eisai Inc.

INDUSTRY

lead

Washington University School of Medicine

OTHER